ENANTA PHARMACEUTICALS INC·4

Mar 8, 5:27 PM ET

Russell Lesley 4

4 · ENANTA PHARMACEUTICALS INC · Filed Mar 8, 2024

Insider Transaction Report

Form 4
Period: 2024-03-06
Transactions
  • Award

    Stock Option (right to buy)

    2024-03-06+15,70015,700 total
    Exercise: $15.66Exp: 2034-03-06Common Stock (15,700 underlying)
Footnotes (1)
  • [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 6, 2024), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2025 annual meeting of stockholders.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES